SCHEMBL7013145

SCHEMBL7013145

c1ccc(Sc2ccc(-n3cnnc3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
QPCT Q16769 1/20 0.43
MAOA P21397 3/20 0.41
MAOB P27338 3/20 0.41
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
CYP3A4 P08684 1/20 0.36
TSHR P16473 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALOX15 P16050 1/20 0.36
MAPT P10636 2/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
HTT P42858 1/20 0.36
SLC6A4 P31645 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL256624 0.79 CYP3A4 (0.52) CYP1A2CYP2C9QPCTALDH1A1HPGD
SCHEMBL7007424 0.77 CYP3A4 (0.69) CYP1A2CYP2C9MAOAMAOBALDH1A1
SCHEMBL29993530 0.77 CYP3A4 (0.50) CYP1A2CYP2C9QPCTALDH1A1HPGD
SCHEMBL7660151 0.76 CYP1A2 (0.38) CYP1A2CYP2C9QPCTALDH1A1HPGD
SCHEMBL23277364 0.74 MAOA (0.62) MAOAMAOBALDH1A1HPGDCYP3A4
SCHEMBL3891569 0.74 MAOA (0.62) MAOAMAOBALDH1A1HPGDCYP3A4
SCHEMBL795030 0.74 MAOA (0.62) MAOAMAOBALDH1A1HPGDCYP3A4
SCHEMBL3891151 0.74 MAOA (0.62) MAOAMAOBALDH1A1HPGDCYP3A4
SCHEMBL7808697 0.71 ALDH1A1 (0.54) CYP1A2CYP2C9QPCTALDH1A1HPGD
SCHEMBL7015795 0.71 CYP1A2 (0.59) CYP1A2CYP2C9QPCTMAOAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1065209-B1 Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-05-02 EP disclosed
US-6339092-B1 FOR THERAPY RHEUMATOID ARTHRITIS, ARTHROSIS, TUMOUR INVASION AND GROWTH, INCLUDING MALIGNANT SPREAD AND THE FORMATION OF METASTASES, ULCERATIONS, ATHEROSCLEROSIS ADIR ET COMPAGNIE (FR) 2002-01-15 US disclosed
EP-1065209-A1 Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 2001-01-03 EP disclosed